Etrasimod
Showing 1 - 22 of 22
Healthy Participants Trial in Brussel (Estraimod Immediate Release (IR), Etrasimod Mini Tab in water, Etrasimod Mini Tab in
Not yet recruiting
- Healthy Participants
- Estraimod Immediate Release (IR)
- +4 more
-
Brussel, BelgiumBrussels Clinical Research Unit
Jul 20, 2023
Colitis, Ulcerative Trial (Etrasimod)
Available
- Colitis, Ulcerative
- Etrasimod
- (no location specified)
Aug 29, 2023
Healthy Participants Trial (Etrasimod Immediate Release (IR))
Not yet recruiting
- Healthy Participants
- Etrasimod Immediate Release (IR)
- (no location specified)
Nov 15, 2023
Ulcerative Colitis Trial in Knoxville (Etrasimod)
Recruiting
- Ulcerative Colitis
- Etrasimod
-
San Francisco, California
- +12 more
Jan 18, 2023
Atopic Dermatitis Trial in United States (Etrasimod, Etrasimod matching )
Completed
- Atopic Dermatitis
- Etrasimod
- Etrasimod matching placebo
-
Tucson, Arizona
- +10 more
Nov 18, 2021
Primary Biliary Cholangitis Trial in Australia, New Zealand, United States (APD334)
Terminated
- Primary Biliary Cholangitis
-
Sacramento, California
- +8 more
Feb 28, 2022
Atopic Dermatitis, Atopic Dermatitis, Unspecified, Eczema Trial in United States (etrasimod, Placebo)
Recruiting
- Atopic Dermatitis
- +3 more
- etrasimod
- Placebo
-
Fountain Valley, California
- +21 more
Feb 22, 2023
Crohn's Disease Trial in Worldwide (Etrasimod, Placebo)
Not yet recruiting
- Crohn Disease
- Etrasimod
- Placebo
- (no location specified)
Aug 29, 2021
Alopecia Areata Trial in Canada, United States (Etrasimod, Placebo)
Active, not recruiting
- Alopecia Areata
- Etrasimod
- Placebo
-
Scottsdale, Arizona
- +41 more
Jan 4, 2023
Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)
Recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Toyohashi-shi, Aichi- KEN, Japan
- +70 more
Jan 3, 2023
IBD, Skin Extra-intestinal Manifestations Trial in Leuven, Hamburg, Belgrade (APD334)
Terminated
- Inflammatory Bowel Diseases
- Skin Extra-intestinal Manifestations
-
Leuven, Belgium
- +2 more
Dec 5, 2020
Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)
Active, not recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Nagoya-shi, Aichi, Japan
- +29 more
Dec 8, 2021
Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)
Active, not recruiting
- Eosinophilic Esophagitis
- Etrasimod
- Placebo
-
Birmingham, Alabama
- +222 more
Dec 8, 2022
Moderately to Severely Active Ulcerative Colitis Trial in Xi'an (Etrasimod, Placebo)
Recruiting
- Moderately to Severely Active Ulcerative Colitis
- Etrasimod
- Placebo
-
Xi'an, Shanxi, ChinaThe First Affiliated Hospital of Fourth Military Medical Univers
Nov 25, 2019
Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)
Recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Dothan, Alabama
- +349 more
Jan 18, 2023
Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)
Completed
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Birmingham, Alabama
- +126 more
Nov 24, 2021
Crohn's Disease Trial in Worldwide (Etrasimod, Placebo)
Recruiting
- Crohn's Disease
- Etrasimod
- Placebo
-
Dothan, Alabama
- +265 more
Mar 17, 2022
Ulcerative Colitis Trial in Worldwide (Etrasimod)
Recruiting
- Ulcerative Colitis
- Etrasimod
-
Dothan, Alabama
- +600 more
Jan 11, 2023
Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)
Completed
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Dothan, Alabama
- +406 more
Jan 11, 2022
Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)
Completed
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Birmingham, Alabama
- +133 more
Mar 10, 2021
Ibd CAncer and seRious Infections in France (I-CARE 2)
Not yet recruiting
- IBD
- +2 more
- Non-interventional
-
Amiens, France
- +1 more
Oct 13, 2023